The potential public health consequences of COVID-19 on malaria in Africa.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
09 2020
Historique:
received: 07 05 2020
accepted: 23 07 2020
pubmed: 10 8 2020
medline: 25 9 2020
entrez: 10 8 2020
Statut: ppublish

Résumé

The burden of malaria is heavily concentrated in sub-Saharan Africa (SSA) where cases and deaths associated with COVID-19 are rising

Identifiants

pubmed: 32770167
doi: 10.1038/s41591-020-1025-y
pii: 10.1038/s41591-020-1025-y
pmc: PMC7613562
mid: EMS153060
doi:

Substances chimiques

Antimalarials 0
Insecticides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1411-1416

Subventions

Organisme : Wellcome Trust
ID : 200222
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Wellcome Trust (Wellcome)
ID : 200222/Z/15/Z
Pays : International
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/R015600/1
Pays : International
Organisme : Wellcome Trust
ID : 200222/Z/15/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom

Références

BMC Infect Dis. 2018 Apr 11;18(1):172
pubmed: 29642869
Lancet Glob Health. 2016 Jul;4(7):e474-84
pubmed: 27269393
Malar J. 2020 Apr 10;19(1):150
pubmed: 32276585
Lancet Infect Dis. 2016 Apr;16(4):465-72
pubmed: 26809816
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Science. 2020 Jul 24;369(6502):413-422
pubmed: 32532802
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367
Malar J. 2019 Jun 11;18(1):195
pubmed: 31186004
PLoS One. 2015 Jan 24;10(1):e0116949
pubmed: 25617837
Lancet. 2016 Apr 23;387(10029):1785-8
pubmed: 26880124
PLoS One. 2013;8(2):e56487
pubmed: 23437143
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Elife. 2016 Aug 22;5:
pubmed: 27547988
Nat Commun. 2018 Nov 26;9(1):4982
pubmed: 30478327
Nat Med. 2020 Jul;26(7):999-1003
pubmed: 32528154
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Bull Math Biol. 2020 Apr 8;82(4):52
pubmed: 32270376
Nat Commun. 2012 Jun 06;3:881
pubmed: 22673908

Auteurs

Ellie Sherrard-Smith (E)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Alexandra B Hogan (AB)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Arran Hamlet (A)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Oliver J Watson (OJ)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Charlie Whittaker (C)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Peter Winskill (P)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Fatima Ali (F)

National Malaria Elimination Programme, Abuja, Nigeria.

Audu B Mohammad (AB)

National Malaria Elimination Programme, Abuja, Nigeria.

Perpetua Uhomoibhi (P)

National Malaria Elimination Programme, Abuja, Nigeria.

Ibrahim Maikore (I)

National Malaria Elimination Programme, Abuja, Nigeria.

Nnenna Ogbulafor (N)

National Malaria Elimination Programme, Abuja, Nigeria.

Jamilu Nikau (J)

National Malaria Elimination Programme, Abuja, Nigeria.

Mara D Kont (MD)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Joseph D Challenger (JD)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Robert Verity (R)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Ben Lambert (B)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Matthew Cairns (M)

Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.

Bhargavi Rao (B)

Manson Unit, Médecins Sans Frontières (Operational Centre Amsterdam), London, UK.

Marc Baguelin (M)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Lilith K Whittles (LK)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

John A Lees (JA)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Sangeeta Bhatia (S)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Edward S Knock (ES)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Lucy Okell (L)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Hannah C Slater (HC)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
PATH, Seattle, WA, USA.

Azra C Ghani (AC)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Patrick G T Walker (PGT)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.

Okefu Oyale Okoko (OO)

National Malaria Elimination Programme, Abuja, Nigeria.

Thomas S Churcher (TS)

MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK. thomas.churcher@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH